According to Zhitong Finance App, Jingyou Pharmaceutical (00858) announced that on October 30, 2026, the company plans to place up to 580 million shares to be placed, accounting for 20% of the company's current issued share capital at the date of this announcement; and about 16.67% of the company's issued share capital expanded by issuing and placing shares. The placement price of HK$0.052 per share was approximately 1.96% higher than the closing price of HK$0.051 per share on October 30. Assuming that the highest number of shares to be placed under the placement agreement, the total proceeds from the placement will be approximately HK$30.2 million, while the net proceeds will be approximately HK$29.4 million. It is anticipated that (a) approximately HK$9.8 million (accounting for approximately 33.33% of the highest net income) will be used to expand the Group's electronic module and related product trading business; (b) approximately HK$19.6 million (accounting for about 66.67% of the highest net income) will be used by the Group to support the commencement of its electronic module and related product manufacturing, sales and research and development business.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.